{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:53:21Z","timestamp":1777114401657,"version":"3.51.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>The aim of this study was to determine the probable relationship between the development of an immediate anaphylactic reaction in a child and the presence of excipients\u2014polyethylene glycol (PEG) 400 and titanium dioxide\u2014in the composition of the drug dydrogesterone (Duphaston). The methodology includes a clinical case analysis that considers anamnestic data, pharmacological evaluation of drug composition, and comparison with relevant literature. The findings indicate that the patient had no allergic history and had previously tolerated medroxyprogesterone therapy without adverse effects. The reaction followed a typical course of immediate anaphylaxis characterized by generalized urticaria, angioedema, bronchospasm, tonic\u2013clonic seizures, and hypotension. Complete resolution of symptoms was achieved after epinephrine administration and antishock therapy. A key distinction between the drugs was identified\u2014the presence of PEG 400 and titanium dioxide exclusively in the formulation that triggered the reaction. These substances are capable of eliciting an immediate immune response even upon initial exposure, without a prior sensitization phase. The mechanism of the reaction is inconsistent with hypersensitivity to progestins, as the reaction occurred on first exposure, was systemic, and involved neurological manifestations. PEG 400 and titanium dioxide therefore have confirmed clinical immunotoxic significance and should be considered separately when evaluating drug reactions. The findings emphasize the importance of personalized drug selection that accounts for the immunoactive potential of excipients and support the inclusion of excipients in diagnostic algorithms for drug hypersensitivity.<\/jats:p>","DOI":"10.1097\/ftd.0000000000001456","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T20:02:06Z","timestamp":1775592126000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Allergy to Macrogol 400 and Titanium Dioxide (E171) as Potential Triggers of Anaphylactic Reaction After Dydrogesterone Intake"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9028-952X","authenticated-orcid":false,"given":"Maria Z.","family":"Lisiecka","sequence":"first","affiliation":[{"name":"Department of Allergology, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Luczak","sequence":"additional","affiliation":[{"name":"Clinic of Allergology and Lung Diseases, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"R2-20260408","doi-asserted-by":"crossref","first-page":"100472","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World Allergy Organization anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"key":"R6-20260408","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"R8-20260408","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/jpm14010079","article-title":"Progesterone hypersensitivity in assisted reproductive technologies: implications for safety and efficacy","volume":"14","author":"Sandru","year":"2024","journal-title":"J Pers Med"},{"key":"R9-20260408","first-page":"55","article-title":"Hypersensitivity to polyethylene glycol (PEG)","volume":"61","author":"Czarnobilska","year":"2021","journal-title":"Folia Med Cracov"},{"key":"R10-20260408","doi-asserted-by":"crossref","first-page":"86","DOI":"10.18176\/jiaci.0476","article-title":"Immediate hypersensitivity reactions caused by drug excipients: a literature review","volume":"30","author":"Caballero","year":"2020","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R11-20260408","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.anai.2024.03.022","article-title":"Polyethylene glycol hypersensitivity, patient outcomes in a 7-year retrospective study","volume":"133","author":"Kayode","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R12-20260408","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaip.2020.09.029","article-title":"Polyethylene glycol\u2013induced systemic allergic reactions (anaphylaxis)","volume":"9","author":"Sellaturay","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R13-20260408","first-page":"e06585","article-title":"Safety assessment of titanium dioxide (E171) as a food additive","volume":"19","author":"Younes","year":"2021","journal-title":"EFSA J"},{"key":"R14-20260408","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/ijms22010207","article-title":"Possible adverse effects of food additive E171 (titanium dioxide) related to particle-specific human toxicity, including the immune system","volume":"22","author":"Bischoff","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R15-20260408","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/nano10020387","article-title":"Titanium dioxide nanoparticles: prospects and applications in medicine","volume":"10","author":"Ziental","year":"2020","journal-title":"Nanomaterials"},{"key":"R16-20260408","first-page":"e44776","article-title":"Progesterone hypersensitivity induced by exogenous progesterone exposure","volume":"15","author":"Dhaliwal","year":"2023","journal-title":"Cureus"},{"key":"R17-20260408","first-page":"e2021519","article-title":"Hypersensitivity to polyethylene glycol in adults and children: an emerging challenge","volume":"92","author":"Bianchi","year":"2021","journal-title":"Acta Biomed"},{"key":"R18-20260408","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/cea.13822","article-title":"Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients","volume":"51","author":"Bruusgaard\u2010Mouritsen","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"R19-20260408","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/jcph.1824","article-title":"PEG that reaction: a case series of allergy to polyethylene glycol","volume":"61","author":"Cox","year":"2021","journal-title":"J Clin Pharmacol"},{"key":"R20-20260408","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1039\/D1EN00833A","article-title":"Toxicological impact of titanium dioxide nanoparticles and food-grade titanium dioxide (E171) on human and environmental health","volume":"9","author":"Fiordaliso","year":"2022","journal-title":"Environ Sci Nano"},{"key":"R21-20260408","first-page":"8","article-title":"Titanium dioxide (E171) and its role in formulation","volume":"28","author":"Tobyn","year":"2023","journal-title":"Eur Pharm Rev"},{"key":"R22-20260408","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3390\/foods10081910","article-title":"Use of food additive titanium dioxide (E171) before the introduction of regulatory restrictions due to concern for genotoxicity","volume":"10","author":"Blaznik","year":"2021","journal-title":"Foods"},{"key":"R23-20260408","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.3390\/ijerph19095681","article-title":"Titanium dioxide: structure, impact, and toxicity","volume":"19","author":"Racovita","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"R24-20260408","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/rmb2.12391","article-title":"An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: an open\u2010label multicenter clinical study","volume":"20","author":"Kitawaki","year":"2021","journal-title":"Reprod Med Biol"},{"key":"R25-20260408","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11882-020-0900-4","article-title":"Progestogen sensitization: a unique female presentation of anaphylaxis","volume":"20","author":"Bernstein","year":"2020","journal-title":"Curr Allergy Asthma Rep"},{"key":"R28-20260408","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.3390\/ijerph17082787","article-title":"Clinical manifestations and causes of anaphylaxis: analysis of 382 cases from the anaphylaxis registry in West Pomerania Province in Poland","volume":"17","author":"Poziomkowska-G\u0119sicka","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"R30-20260408","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/imj.16605","article-title":"Excipient-induced allergies in oral medications: unravelling the covert threat\u2014a systematic review","volume":"55","author":"Seth","year":"2025","journal-title":"Intern Med J"},{"key":"R31-20260408","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40521-022-00313-6","article-title":"New challenges in drug allergy: the resurgence of excipients","volume":"9","author":"Venturini D\u00edaz","year":"2022","journal-title":"Curr Treat Options Allergy"},{"key":"R32-20260408","doi-asserted-by":"crossref","first-page":"1331036","DOI":"10.3389\/falgy.2023.1331036","article-title":"Feasibility of a drug allergy registry-based excipient allergy database and call for universal mandatory drug ingredient disclosure: the case of PEG","volume":"4","author":"Kan","year":"2023","journal-title":"Front Allergy"},{"key":"R33-20260408","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/all.15913","article-title":"Allergological reappraisal of the annex to the European Commission guideline on excipients (SANTE\u20102017\u201011,668)","volume":"79","author":"Caballero","year":"2024","journal-title":"Allergy"},{"key":"R34-20260408","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/aje\/kwac182","article-title":"Improving methods of identifying anaphylaxis for medical product safety surveillance using natural language processing and machine learning","volume":"192","author":"Carrell","year":"2023","journal-title":"Am J Epidemiol"},{"key":"R35-20260408","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1097\/PTS.0000000000000711","article-title":"Improving allergy documentation: a retrospective electronic health record system\u2013wide patient safety initiative","volume":"18","author":"Li","year":"2022","journal-title":"J Patient Saf"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T02:00:10Z","timestamp":1775613610000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":27,"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001456","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"2025-12-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}